Best practice considerations by the American Society of Transplant and Cellular Therapy: Infection prevention and management after chimeric antigen receptor T cell therapy for hematological malignancies
Last Updated: Tuesday, December 9, 2025
The Infectious Diseases Special Interest Group of the American Society of Transplantation and Cellular Therapy convened an expert panel to develop best practice recommendations for infection prevention and management in CAR T-cell therapy recipients, emphasizing the importance of early Infectious Diseases consultation during treatment planning.
Advertisement
News & Literature Highlights
